ATCC announces award from national institute of allergy and infectious diseases to support its preclinical services for biopharmaceutical product development

ATCC today announced that it has been awarded an Indefinite Delivery/Indefinite Quantity (IDIQ) contract.

Verastem’s stock takes a hit after sharing updated filing plans in ovarian cancer

For a moment, Verastem Oncology looked like one of the early winners of the American Society of Clinical Oncology’s annual meeting. The company’s shares $VSTM

May 25, 2024

Wearable devices and machine learning revolutionize Parkinson’s disease monitoring

The quantitative progression of motor symptoms of Parkinson’s disease (PD) over time using wearable sensor data.

October 11, 2023

EZH2 inhibitors enhance effectiveness of cancer immunotherapies

An emerging class of anticancer drugs called EZH2 inhibitors may greatly enhance the potency of some cancer immunotherapies, according to a preclinical study led by

December 6, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.